Skip to main content

Day: August 13, 2025

Mag Mile Capital Arranges $15.9 Million in Financing for Hampton Inn El Paso, Texas Acquisition

Chicago, Illinois, Aug. 13, 2025 (GLOBE NEWSWIRE) — Mag Mile Capital is pleased to announce the successful arrangement of $15.9 million in total financing for the acquisition of the Hampton Inn El Paso, located at 6635 Gateway Blvd W, El Paso, Texas. The transaction was arranged on behalf of Nexgen Management, a Dallas-based hotel ownership and management firm with extensive expertise in the Texas border market. The financing package consisted of a $13.9 million senior CMBS loan and a $2 million mezzanine loan, representing over 80% loan-to-purchase price leverage. The five-year, fixed-rate structure provides the Sponsor with long-term stability while maximizing proceeds. This transaction was originated by Michael Taylor, Vice President of Originations, and Prabhat Jayara, Vice President of Originations, at Mag Mile Capital. “Finding...

Continue reading

Silvaco’s CEO, Babak Taheri, to Attend the Jefferies’ Semis, IT Hardware & Comm Tech Summit in Chicago

SANTA CLARA, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Silvaco Group, Inc. (Nasdaq: SVCO, “Silvaco”), a provider of TCAD, EDA software, and SIP solutions that enable innovative semiconductor design and digital twin modeling through AI software and innovation, today announced that Silvaco’s Chief Executive Officer, Dr. Babak Taheri, will be participating in the Jefferies’ Semis, IT Hardware & Comm Tech Summit in Chicago. Date: Tuesday, August 26 – Wednesday, August 27, 2025Time: 9:00 a.m. – 5:00 p.m. Central Daylight Time About SilvacoSilvaco is a provider of TCAD, EDA software, and SIP solutions that enable semiconductor design and digital twin modeling through AI software and innovation. Silvaco’s solutions are used for semiconductor and photonics processes, devices, and systems development across display, power devices, automotive,...

Continue reading

Form 8.5 (EPT/RI) – Anexo Group Plc – AMENDMENT

FORM 8.5 (EPT/RI) PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”) 1.        KEY INFORMATION(a)        Name of exempt principal trader: Shore Capital Stockbrokers Ltd(b)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Anexo Group Plc(c)        Name of the party to the offer with which exempt principal trader is connected: Anexo Group Plc(d)        Date dealing undertaken: 06 August 2025(e)        Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer? No2.        DEALINGS BY THE EXEMPT PRINCIPAL TRADER (a)        Purchases and salesClass...

Continue reading

Diana Shipping Inc. Announces Time Charter Contract for m/v Polymnia with Oldendorff Carriers

ATHENS, Greece, Aug. 13, 2025 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that through a separate wholly-owned subsidiary, it has entered into a time charter contract with Oldendorff Carriers GmbH & Co. KG, for one of its Post-Panamax dry bulk vessels, the m/v Polymnia. The gross charter rate is US$14,000, minus a 5.00% commission paid to third parties, for a period until minimum April 10, 2026 up to maximum June 10, 2026. The charter is expected to commence on August 17, 2025. The “Polymnia” is a 98,704 dwt Post-Panamax dry bulk vessel built in 2012. The employment of “Polymnia” is anticipated to generate approximately US$3.28 million of gross revenue for the minimum scheduled period...

Continue reading

Abits Group Inc Reports Unaudited Financial Results for the First Half of 2025

Hong Kong, Aug. 13, 2025 (GLOBE NEWSWIRE) — Abits Group Inc (NASDAQ: ABTS) is pleased to announce its half-year results for the period ended June 30, 2025. The operating profit from mining operations for the six months to June 30, 2025 was $2.138 million, an improvement of nearly 6% from the corresponding period last year. This was despite the halving of the mining rewards from late April 2024 which reduced total output to 40.27 bitcoins in the first half of 2025 (61.53 bitcoins in the same period of 2024). An improvement in the average price of bitcoins of $95,843 (2024: $59,628) and a maiden contribution from the Memphis hosting facility in the last quarter helped to compensate for the shortfall. The loss before interest and taxation was $0.25 million (2024:$0.14 million) due to a higher depreciation charge for the additional...

Continue reading

Draft Season is Here: Samuel Adams Celebrates Octoberfest and Fantasy Football’s Return

America’s #1 fall seasonal beer [1], teams up with fantasy football fanatic and The Office’s Brian Baumgartner for a limited-edition drop that honors the league heroes — the commissioners.Samuel Adams Powers Draft Day with Octoberfest and the Fall Legends Commissioner’s KitBrian Baumgartner celebrates the return of Samuel Adams Octoberfest and fantasy football.Boston, MA, Aug. 13, 2025 (GLOBE NEWSWIRE) — Samuel Adams, one of the pioneers of the craft beer movement and the brewer behind #1 best-selling fall seasonal Octoberfest [1], is gearing up for football season by honoring the real MVPs of fantasy football: the commissioners. To celebrate the legendary role, the brand is dropping the limited-edition Fall Legends Commissioner’s Kit. The kit includes everything a commissioner needs to rule a league: a gavel to rule...

Continue reading

Creative Medical Technology Holdings Secures FDA Fast Track Designation for CELZ-201-DDT – Advancing Breakthrough Therapy for Chronic Lower Back Pain

PHOENIX, Aug. 13, 2025 (GLOBE NEWSWIRE) — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a clinical-stage biotechnology company focused on regenerative and immune cellular therapies, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to its lead investigational therapy, CELZ-201-DDT, for the treatment of degenerative disc disease (DDD), a major cause of chronic lower back pain and disability. This designation positions CELZ-201-DDT among a select group of therapies recognized for their potential to address serious medical conditions with high unmet need. Fast Track status enables the Company to benefit from accelerated FDA interactions, rolling Biologics License Application (BLA) submissions, and eligibility for priority review—potentially expediting the path to market...

Continue reading

MAIA Biotechnology Granted European Patent for Next Generation Telomere-Targeting Agents for Cancer Therapy

Cancer-fighting immunosuppressive agents shown to disrupt telomeres and suspend growth of cancer cells  CHICAGO , Aug. 13, 2025 (GLOBE NEWSWIRE) — MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a clinical-stage biopharmaceutical company focused on developing targeted immunotherapies for cancer, today announced that the European Patent Office has decided to grant a patent broadly covering a portfolio of ateganosine-based analogues for telomere-targeting anticancer therapy and methods of using ateganosine (THIO) alone or before administration of checkpoint inhibitors (CPIs). The patent, titled “Mercaptopurine Ribonucleoside Analogues for Altering Telomerase Mediated Telomere,” was invented by MAIA’s Chief Scientific Officer Sergei M. Gryaznov, PhD and Scientific Advisory Board member Jerry W. Shay, PhD. “Mercaptopurine...

Continue reading

Interlink Electronics Reports Strong Second Quarter 2025 Results

Q2 2025 Revenue up 18%, Driving Solid Gross Margins and Profitability Beginning Production on Integrated Sensing Solution for Division of Top 10 Global OEM Awarded $280K SBIR Grant, Underscoring Interlink’s Leading Position in the Gas Sensing IndustryFREMONT, Calif., Aug. 13, 2025 (GLOBE NEWSWIRE) — Interlink Electronics, Inc. (Nasdaq: LINK) (“Interlink” or the “Company”), a global leader in sensor technology and printed electronic solutions, today reported results for the second quarter ended June 30, 2025. The second quarter of 2025 marked a pivotal step in Interlink’s mission to become a global leader in sensor technology and printed electronic solutions. Progress on key strategic initiatives is positioning the company to achieve its growth and profitability objectives. Q2 2025 and Recent HighlightsRevenue growth: Increased...

Continue reading

ASUS Launches V400 AiO Series in Canada

Minimalist design, smart functionality, and advanced features for effortless productivity, creativity, and entertainment — now in Canada in 24- or 27-inch models KEY POINTSSleek NanoEdge display: Slim and lightweight with a sleek NanoEdge display offering up to 93% screen-to-body ratio Compact, streamlined beauty: Minimalist aesthetic with a 38%-reduced bezel height and 25%-thinner profile compared to previous designs Immersive audio: Powerful hi-fi stereo speakers with Dolby® Atmos and advanced bass-reflex design Secure by design: Retractable camera for instant privacy, built in TPM 2.0 to store authentication information and Kensington Nano lock slotTORONTO, Aug. 13, 2025 (GLOBE NEWSWIRE) — ASUS today announced the availability of the ASUS V400 AiO, a new series of slim, sleek and powerful all-in-one PCs designed for modern...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.